Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
It’s getting harder to see a cardiologist | 3D echo & young patients | FDA approves pacing lead for LBBAP | TAVR & radiotherapy
Tuesday, February 24, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

It’s about to get harder for many Medicare patients to see a cardiologist

UnitedHealthcare now requires patients enrolled in certain Medicare Advantage plans to receive a PCP referral before seeing a cardiologist. On May 1, the insurer will start denying all claims that do not include the necessary referral. UnitedHealthcare argues that "stronger PCP engagement" is good for patient care, but many stakeholders disagree.

READ MORE >
Referral
Share on Twitter Share on Facebook Share on Linkedin

It’s about to get harder for many Medicare patients to see a cardiologist

Share on Twitter Share on Facebook Share on Linkedin
Referral
UnitedHealthcare now requires patients enrolled in certain Medicare Advantage plans to receive a PCP referral before seeing a cardiologist. On May 1, the insurer will start denying all claims that do not include the necessary referral. UnitedHealthcare argues that "stronger PCP engagement" is good for patient care, but many stakeholders disagree.
READ MORE >

ASE promoting 3D echo as a better way to treat congenital heart disease

The introduction of a 3D pediatric transesophegeal echo probe is having a major impact on how these pediatric congenital heart patients are being treated.

READ MORE >
Pei-Ni Jone explains ASE push for 3D TEE in congenital heart
Share on Twitter Share on Facebook Share on Linkedin

ASE promoting 3D echo as a better way to treat congenital heart disease

Share on Twitter Share on Facebook Share on Linkedin
Pei-Ni Jone explains ASE push for 3D TEE in congenital heart
The introduction of a 3D pediatric transesophegeal echo probe is having a major impact on how these pediatric congenital heart patients are being treated.
READ MORE >

FDA approves new Biotronik pacing lead for LBBAP

The next-generation device includes a stylet-driven lead and a fixed helix. It was designed and developed specifically with LBBAP in mind. 

READ MORE >
Biotronik has secured U.S. Food and Drug Administration (FDA) approval for its Solia CSP S pacing lead for left bundle branch area pacing (LBBAP).
Share on Twitter Share on Facebook Share on Linkedin

FDA approves new Biotronik pacing lead for LBBAP

Share on Twitter Share on Facebook Share on Linkedin
Biotronik has secured U.S. Food and Drug Administration (FDA) approval for its Solia CSP S pacing lead for left bundle branch area pacing (LBBAP).
The next-generation device includes a stylet-driven lead and a fixed helix. It was designed and developed specifically with LBBAP in mind. 
READ MORE >

TAVR a safe treatment option for patients who have undergone chest radiation therapy

In fact, researchers wrote, TAVR and SAVR were linked to comparable long-term outcomes for heart patients who have previously been exposed to mediastinal radiation. 

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

TAVR a safe treatment option for patients who have undergone chest radiation therapy

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
In fact, researchers wrote, TAVR and SAVR were linked to comparable long-term outcomes for heart patients who have previously been exposed to mediastinal radiation. 
READ MORE >

Featured Articles

Death after PCI seen in just 0.5% of patients—heart attack, cardiac arrest most common causes

The new analysis included data from more than 22,000 PCI patients treated at one of two high-volume U.S. facilities. Infection was the most common noncardiac cause of death.

READ MORE >
IVUS guidance during DES implantation boosts long-term outcomes in new study
Share on Twitter Share on Facebook Share on Linkedin

Death after PCI seen in just 0.5% of patients—heart attack, cardiac arrest most common causes

Share on Twitter Share on Facebook Share on Linkedin
IVUS guidance during DES implantation boosts long-term outcomes in new study
The new analysis included data from more than 22,000 PCI patients treated at one of two high-volume U.S. facilities. Infection was the most common noncardiac cause of death.
READ MORE >

Cardiologist says new legislation would delay flawed payment cuts, preserve access to care

The efficiency adjustment cuts introduced in the 2026 MPFS are based on assumptions many doctors believe to be false. The American Society of Nuclear Cardiology and other medical societies are pushing back.

READ MORE >
Friederike Keating, MD, director, nuclear cardiology, at University of Vermont Health, and chair of American Society of nuclear Cardiology (ASNC) Health Policy Committee, explains the support behind House Bill 7520 that aims to halt the Medicare's 2.5% efficiency adjustment cut to physician payments that was included in the 2025 Medicare Physician Fee Schedule.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist says new legislation would delay flawed payment cuts, preserve access to care

Share on Twitter Share on Facebook Share on Linkedin
Friederike Keating, MD, director, nuclear cardiology, at University of Vermont Health, and chair of American Society of nuclear Cardiology (ASNC) Health Policy Committee, explains the support behind House Bill 7520 that aims to halt the Medicare's 2.5% efficiency adjustment cut to physician payments that was included in the 2025 Medicare Physician Fee Schedule.
The efficiency adjustment cuts introduced in the 2026 MPFS are based on assumptions many doctors believe to be false. The American Society of Nuclear Cardiology and other medical societies are pushing back.
READ MORE >

Registry data point to ‘striking shift’ in treatment decisions after FDA approved low-risk TAVR

Many experts still recommend SAVR over TAVR for patients younger than 65 years old with severe aortic stenosis. However, transcatheter treatments are growing more and more popular when these younger patients require a valve replacement.

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

Registry data point to ‘striking shift’ in treatment decisions after FDA approved low-risk TAVR

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Many experts still recommend SAVR over TAVR for patients younger than 65 years old with severe aortic stenosis. However, transcatheter treatments are growing more and more popular when these younger patients require a valve replacement.
READ MORE >

New study of homozygous familial hypercholesterolemia finds higher LDL-C levels in women

The American Society for Preventive Cardiology celebrated researchers for uncovering new insights into this rare condition.

READ MORE >
older female patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

New study of homozygous familial hypercholesterolemia finds higher LDL-C levels in women

Share on Twitter Share on Facebook Share on Linkedin
older female patient and doctor
The American Society for Preventive Cardiology celebrated researchers for uncovering new insights into this rare condition.
READ MORE >

In Case You Missed It

Interventional cardiologists implant new-look heart device for first time in US

The Amend device from Valcare Medical has a closed ring shape similar to the annuloplasty rings used to treat MR during open-heart surgeries. These early patients will be followed for a total of five years.

READ MORE >
Valcare Medical’s Amend Transseptal System for mitral regurgitation
Share on Twitter Share on Facebook Share on Linkedin

Interventional cardiologists implant new-look heart device for first time in US

Share on Twitter Share on Facebook Share on Linkedin
Valcare Medical’s Amend Transseptal System for mitral regurgitation
The Amend device from Valcare Medical has a closed ring shape similar to the annuloplasty rings used to treat MR during open-heart surgeries. These early patients will be followed for a total of five years.
READ MORE >

Nasal spray for paroxysmal supraventricular tachycardia enters US market

New drug allows patients to self-treat PSVT. About 2 million people in the U.S. have been diagnosed with condition.

READ MORE >
New data from the Phase 3 RAPID clinical trial of etripamil, an investigational calcium channel blocker nasal spray, showed positive results in converting paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm in the at-home setting. The presentation was featured during a late-breaking clinical trials session at the American Heart Association (AHA) 2022 Scientific Sessions. #AHA22
Share on Twitter Share on Facebook Share on Linkedin

Nasal spray for paroxysmal supraventricular tachycardia enters US market

Share on Twitter Share on Facebook Share on Linkedin
New data from the Phase 3 RAPID clinical trial of etripamil, an investigational calcium channel blocker nasal spray, showed positive results in converting paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm in the at-home setting. The presentation was featured during a late-breaking clinical trials session at the American Heart Association (AHA) 2022 Scientific Sessions. #AHA22
New drug allows patients to self-treat PSVT. About 2 million people in the U.S. have been diagnosed with condition.
READ MORE >

Comparable long-term survival seen in two common CABG strategies

STS late-breaking study found BITA and SITA+RA have similar long-term survival, but age plays a role in which to choose.

READ MORE >
CABG coronary artery bypass grafting heart surgery
Share on Twitter Share on Facebook Share on Linkedin

Comparable long-term survival seen in two common CABG strategies

Share on Twitter Share on Facebook Share on Linkedin
CABG coronary artery bypass grafting heart surgery
STS late-breaking study found BITA and SITA+RA have similar long-term survival, but age plays a role in which to choose.
READ MORE >

In Other News

New group names 4 things US healthcare can—and should—handle on behalf of Alzheimer’s patients, caregivers

Alzheimer’s disease already has the nation in a crisis of care capacity. The pressure to do more in response is mounting. Meanwhile the true total cost is hard to estimate since so many dementia caregivers are unpaid family members and other volunteers. 

READ MORE >
Elder caree
Share on Twitter Share on Facebook Share on Linkedin

New group names 4 things US healthcare can—and should—handle on behalf of Alzheimer’s patients, caregivers

Share on Twitter Share on Facebook Share on Linkedin
Elder caree
Alzheimer’s disease already has the nation in a crisis of care capacity. The pressure to do more in response is mounting. Meanwhile the true total cost is hard to estimate since so many dementia caregivers are unpaid family members and other volunteers. 
READ MORE >

With SCOTUS striking down ‘Liberation Day’ tariffs, Trump implements 15% tax on all imports

The U.S. Supreme Court ruled President Donald Trump’s sweeping global tariffs unconstitutional. The administration responded by imposing a 10% rate across the board, later hiked to 15%. That will remain in effect for 150 days and require an act of Congress to extend.

READ MORE >
U.S. Supreme Court building SCOTUS
Share on Twitter Share on Facebook Share on Linkedin

With SCOTUS striking down ‘Liberation Day’ tariffs, Trump implements 15% tax on all imports

Share on Twitter Share on Facebook Share on Linkedin
U.S. Supreme Court building SCOTUS
The U.S. Supreme Court ruled President Donald Trump’s sweeping global tariffs unconstitutional. The administration responded by imposing a 10% rate across the board, later hiked to 15%. That will remain in effect for 150 days and require an act of Congress to extend.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup